Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ProMIS Neurosciences Inc. (PMN)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Dec-31-21 | Dec-31-20 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-K | |
| Assets |
| Cash and equivalents | 1.2 | 3.3 | 5.9 | 3.9 | 8.9 | 16.9 | |
| Short-term investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other current assets | 0.2 | 1.0 | 1.0 | 1.4 | 1.2 | 0.7 | |
| Total current assets | 1.5 | 4.4 | 6.9 | 5.4 | 10.2 | 17.7 | |
| Property, plant, and equipment, net | | | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangibles | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total assets | 1.5 | 4.4 | 6.9 | 5.4 | 10.2 | 17.7 | |
| |
| Accounts payable | 8.0 | 7.0 | 3.0 | 1.8 | 0.9 | 0.4 | |
| Accrued expenses | 0.8 | 1.7 | 3.4 | 1.3 | 1.0 | 1.5 | |
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other current liabilities | | | | | | -1.0 | |
| Total current liabilities | 8.7 | 8.7 | 6.4 | 3.1 | 1.9 | 0.9 | |
| Long-term debt | | | | | | 3.9 | |
| Other liabilities | 1.3 | 1.9 | 1.9 | 1.6 | 1.6 | 7.3 | |
| Total liabilities | 10.0 | 10.6 | 8.3 | 4.7 | 3.5 | 12.1 | |
| |
| Shareholders' equity [+] | -8.5 | -6.2 | -1.3 | 0.7 | 6.7 | 5.7 | |
| Paid-in capital | 79.4 | 79.2 | 79.1 | 74.0 | 73.9 | 68.0 | |
| Retained earnings | -87.5 | -85.2 | -80.3 | -73.0 | -67.0 | -62.2 | |
| Tangible shareholders' equity | -8.5 | -6.2 | -1.4 | 0.7 | 6.7 | 5.6 | |
|